Literature DB >> 2257444

The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.

A M Sebastião1, T W Stone, J A Ribeiro.   

Abstract

1. The ability of 1,3,8-substituted xanthines to antagonize the inhibitory effects of adenosine receptor agonist on the amplitude of nerve-evoked twitches of the rat phrenic-diaphragm and on the amplitude of orthodromically-evoked population spikes, recorded from the CA1 pyramidal cells of rat hippocampal slices, was investigated. 2. 1,3-Dipropyl-8-cyclopenthylxanthine (DPCPX), 1,3-dipropyl-8-(carboxymethyloxyphenyl)xanthine (XCC), 1,3-dipropyl-8-(4-[2-aminoethyl)amino)carbonylmethyloxyphenyl)x ant hine (XAC), 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX), 8-phenyltheophylline (8-PT), 1,3-diethyl-8-phenylxanthine (DPX) and PD 115,199, in concentrations virtually devoid of effect on neuromuscular transmission, shifted to the right in a near parallel manner the log concentration-response curve for the inhibitory effect of 2-chloroadenosine (CADO) on nerve-evoked twitches of the phrenic-diaphragm. Linear Schild plots with slopes near to unity were obtained for all the xanthines. 3. The order of potency of the xanthines as antagonists of the effect of CADO in the phrenic-diaphragm was DPCPX (Ki = 0.54 nM) greater than XCC (Ki = 10 nM), XAC (Ki = 11 nM), PACPX (Ki = 13 nM) greater than DPX (Ki = 22 nM), 8-PT (Ki = 25 nM) greater than PD 115,199 (Ki = 57 nM). The potency of DPCPX in antagonizing the inhibitory effects of R-N6-phenylisopropyladenosine (R-PIA) and 5'-N-ethylcarboxamide adenosine (NECA) on nerve-evoked twitch response was not statistically different from its potency in antagonizing the inhibitory effect on CADO. 4. In the hippocampal slices, DPCPX, XCC and XAC, used in concentrations virtually devoid of effect on population spike amplitude, shifted to the right in a near parallel manner the log concentrationresponse curve for the inhibitory effect of CADO on the amplitude of the population spikes. The Schild plots were linear with slopes near unity. 5. The potencies of DPCPX (K, = 0.45 nM) and XAC (K, = 11 nM) in antagonizing the inhibitory adenosine receptor at the hippocampus were similar to their potencies for antagonism of the inhibitory adenosine receptor at the phrenic-diaphragm. XCC was only slightly more potent (K, = 5.4 nM) as an antagonist of the adenosine receptor in the hippocampus than in the phrenic-diaphragm. 6. The results suggest that the inhibitory adenosine receptors in the phrenic-diaphragm and in the hippocampus of the rat are similar, and that according to the antagonist potencies, these receptors belong to the A1-adenosine receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257444      PMCID: PMC1917689          DOI: 10.1111/j.1476-5381.1990.tb12729.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

2.  The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions.

Authors:  J A Ribeiro; J Walker
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

Review 3.  Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor.

Authors:  J A Ribeiro; A M Sebastião
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

4.  The inhibitory effects of some adenosine analogues on transmitter release at the mammalian neuromuscular junction.

Authors:  Y N Singh; W F Dryden; H Chen
Journal:  Can J Physiol Pharmacol       Date:  1986-11       Impact factor: 2.273

5.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction.

Authors:  J A Ribeiro; A M Sebastião
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

7.  Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.

Authors:  D Ukena; J W Daly; K L Kirk; K A Jacobson
Journal:  Life Sci       Date:  1986-03-03       Impact factor: 5.037

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation.

Authors:  T V Dunwiddie; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

10.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

View more
  28 in total

1.  Interactions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice.

Authors:  Ali Shahraki; Trevor W Stone
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

3.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

Review 4.  Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors.

Authors:  R A Cunha; A M Sebastião; J A Ribeiro
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

5.  Regional Variations of Spontaneous, Transient Adenosine Release in Brain Slices.

Authors:  Scott T Lee; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2017-11-27       Impact factor: 4.418

6.  Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides.

Authors:  R A Cunha; P Correia-de-Sá; A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

8.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

10.  On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.

Authors:  J C Oliveira; A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.